🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
First, the investigators will image patients with hyperpolarized xenon (Xe)...
Status
Completed
Location
University of Virginia
Start Date
2016-05-01
Trial ID
NCT02826343
Treatments Being Tested
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10
Trial ID
NCT03562923
Treatments Being Tested
This retrospective database study will assess differences in the risk of re...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01381458
The purpose of this study is to understand why patients in the World Trade ...
Status
Completed
Location
New York University School of Medicine
Start Date
2014-04-09
Trial ID
NCT02024204
Evaluate the additive role of zileuton 600mg qid to clinically stable asthm...
Status
Completed
Location
Arthur F Gelb Medical Corporation
Start Date
2005-09
Trial ID
NCT00575861
Treatments Being Tested
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2018-11-20
Trial ID
NCT03751202
Treatments Being Tested
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
The purpose of this study is to compare the early onset of effect of Symbic...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00646620
Treatments Being Tested